Related Experiment Video
Updated: Aug 11, 2026

A Multiplexed Luciferase-based Screening Platform for Interrogating Cancer-associated Signal Transduction in Cultured Cells
Published on: July 3, 2013
Overexpressed FOXM1 collaborates with MMB to increase WEE1 inhibitor sensitivity in NSCLC
Jian Tan1, Jingbo Ma1, Weiqiang Zhang1
1Department of Thoracic Surgery, Seventh Medical Center of Chinese PLA General Hospital, Beijing, China.
Background:
Non-small cell lung cancer (NSCLC) is a common lung tumor with high mortality. The complex formed by MYB-MuvB complex (MMB) and forkhead box M1 (FOXM1) (MMB-FOXM1) plays a vital role in cell cycle progression to affect the progression of diseases. The role of the FOXM1-MMB complex in Wee1-like protein kinase (WEE1) inhibitor sensitivity in NSCLC keeps unclear.
Methods:
The reverse transcription quantitative polymerase chain reaction (RT-qPCR) was performed to measure the mRNA levels of FOXM1, LIN54, Replication Protein A (RPA), gammaH2AX (γH2AX) and Cyclin B (CCNB). The western blot was performed to examine the corresponding protein expressions. The Cell Counting Kit-8 (CCK-8) assay was performed to test cell survival.
Result:
It was demonstrated that after AZD-1775 treatment, the decrease in cell survival mediated by FOXM1 overexpression (P<0.001) could be reversed by LIN54 knockdown (P<0.01) and that cell survival in the control group did not differ obviously from that in the pcDNA3.1-FOXM1+siLIN54 group, indicating that the FOXM1-MMB complex was necessary for WEE1 inhibitor sensitivity. Moreover, the mRNA and protein expression levels of RPA and γH2AX were increased after AZD-1775 treatment and FOXM1 overexpression (P<0.01), suggesting that FOXM1 upregulation enhanced DNA replication stress and DNA damage. Finally, we found that the increases in the mRNA and protein expression levels of CCNB mediated by FOXM1 (P<0.01) could be rescued by silencing LIN54 (P<0.001) and that CCNB expression in the control group did not differ obviously from that in the pcDNA3.1-FOXM1+siLIN54 group. These findings revealed that the FOXM1-MMB complex activated G2/M checkpoints. In our work, it was discovered that FOXM1 overexpression increased DNA replication stress, which increased DNA replication and pressure on the WEE1 checkpoint. On the other hand, FOXM1 can enhance CCNB expression, increase the threshold content of the CCNB/CDK1 complex, facilitate mitosis, and promote WEE1 dephosphorylation. Under these two conditions, sensitivity to the WEE1 inhibitor AZD-1775 is increased, which leads to the accumulation of DNA damage and drives the activation of apoptosis.
Conclusions:
Overexpressed FOXM1 collaborates with MMB to increase WEE1 inhibitor sensitivity in NSCLC. This discovery might highlight the regulatory function of FOXM1/MMB in the treatment of NSCLC patients.
Insights
Forkhead box M1 (FOXM1) and MYB-MuvB complex (MMB) interaction enhances sensitivity to WEE1 inhibitors in non-small cell lung cancer (NSCLC). This FOXM1-MMB complex promotes DNA replication stress and activates checkpoints, offering new therapeutic strategies for NSCLC.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Non-small cell lung cancer (NSCLC) presents a significant mortality challenge.
- The MYB-MuvB (MMB) complex interacting with forkhead box M1 (FOXM1) is crucial for cell cycle progression.
- The precise role of the FOXM1-MMB complex in WEE1 inhibitor sensitivity within NSCLC remains largely undetermined.
Purpose of the Study:
- To elucidate the role of the FOXM1-MMB complex in modulating WEE1 inhibitor sensitivity in NSCLC.
- To investigate how FOXM1 affects DNA replication stress, DNA damage, and cell cycle checkpoints in response to WEE1 inhibition.
- To determine the therapeutic implications of targeting the FOXM1-MMB complex in NSCLC treatment.
Main Methods:
- Quantitative polymerase chain reaction (RT-qPCR) to assess mRNA levels of FOXM1, LIN54, RPA, γH2AX, and CCNB.
- Western blotting to evaluate corresponding protein expression levels.
- Cell Counting Kit-8 (CCK-8) assay to determine cell viability and response to AZD-1775 treatment.
Main Results:
- FOXM1 overexpression significantly decreased cell survival under WEE1 inhibition, an effect reversed by LIN54 knockdown, confirming the necessity of the FOXM1-MMB complex.
- FOXM1 upregulation intensified DNA replication stress and DNA damage, evidenced by increased RPA and γH2AX expression.
- The FOXM1-MMB complex was shown to activate G2/M checkpoints by enhancing CCNB expression and promoting WEE1 dephosphorylation, thereby increasing sensitivity to the WEE1 inhibitor AZD-1775.
Conclusions:
- Overexpressed FOXM1, in conjunction with the MMB complex, enhances WEE1 inhibitor sensitivity in NSCLC.
- The FOXM1-MMB complex plays a critical regulatory role in NSCLC pathogenesis and response to targeted therapies.
- Targeting the FOXM1-MMB pathway presents a promising therapeutic strategy for NSCLC patients.
Related Concept Videos
Master Transcription Regulators
Canonical Wnt Signaling Pathway
Abnormal Proliferation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...

